PE operating partner reviewing a portfolio company marketing governance framework across several holdings

Portfolio Company Marketing Governance: Why You Can’t Evaluate Every Company From Scratch

What it is: Portfolio company marketing governance is a repeatable standard operating procedure that partners apply to every portfolio company they hold, to check whether marketing is owned, systemized, and tied to revenue.

Why it matters: Without one standard, every company gets evaluated from scratch, findings aren’t comparable, and marketing gaps stay anecdotal instead of reaching the board as decision-grade findings.

Who it is for: PE-backed operating partners, portfolio company leaders, and value creation teams accountable for marketing performance across more than one holding.

Let’s be honest: every time you inherit a portfolio company, you inherit its marketing exactly as it is. Sometimes that’s a marketing director running a reasonable playbook. More often it’s a pile of disconnected activity: a website nobody has touched since acquisition, an agency retainer nobody remembers approving, a social calendar with no link to pipeline, and a GM who describes marketing spend as “what we’ve always done.” You can’t build portfolio company marketing governance on that kind of inconsistency. Without a repeatable framework, you end up reassessing marketing from zero at every company, on every deal, with no way to tell in week one whether you’re looking at a real constraint or just noise. That inconsistency is expensive. Not because any single company’s marketing waste is large on its own, but because it compounds across a portfolio. Three or four companies each burning six figures a year on ungoverned marketing spend is not a rounding error. It’s a value creation lever sitting untouched, and it’s the kind of thing an investment committee eventually asks you to explain.

Activity Metrics Tell You Nothing About Portfolio Risk

At the individual company level, the dashboards will usually look fine. Traffic is up. Impressions are up. Someone on the team can point to a chart with a green arrow. None of that tells you what you actually need to know: is this company’s marketing spend producing a repeatable pipeline, or is it producing motion that happens to correlate with revenue that would have shown up anyway? The distinction matters more in a portfolio context than it does for a single owner-operator. A CEO running one company can afford to slowly figure out whether marketing is working. An operating partner accountable to a board across several companies cannot. You need a way to look at Company A and Company B on the same terms and get a comparable answer, fast, in language your investment committee will accept without a follow-up meeting. Vanity metrics don’t travel across companies. A governance framework does.

The Three-Lens Diagnostic: Ownership, System, Governance

In my experience, the constraint on growth rarely sits inside the marketing function itself. It sits upstream, in one of three places, and that holds true whether you’re looking at one company or ten.

Ownership

At each portfolio company, who is accountable, at the executive level, for the growth number? Not who runs the campaigns. Who owns the strategy and answers for the result? When the honest answer is “no one, really” or “the GM, by default,” that’s a governance gap you can flag in week one of any evaluation, before you spend a dollar on execution. I’ve written before about how this exact gap forms inside a single company, before it ever reaches portfolio scale.

System

Does the company’s marketing feed a repeatable process that produces a pipeline every month, or is every new customer a surprise tied to a referral or a salesperson’s relationships? A company running on referral luck isn’t a marketing case. It’s a structural risk case, and it belongs on the same risk register as customer concentration or key-person dependency.

Governance

Ask the marketing leader at any portfolio company three questions: What is the budget? What revenue is it responsible for? Who measures whether it worked? If those three questions take longer than ten seconds to answer cleanly, marketing is being spent, not governed, at that company. That’s a finding you can put in a board deck without qualification. Running this same three-lens check at acquisition, at the twelve-month mark, and again pre-exit gives you a standard instead of a guess, and it gives every portfolio company leader the same rules to operate under.

Same Pattern, Three Different Constraints

Here’s the hard truth: the same three-lens read applied across a portfolio rarely turns up the same answer twice. Three companies can all look like they “need more marketing,” and each one needs something different.
Company Symptom Constraint Right Move
Company A Has spend: an agency, a budget line, a reasonable-looking plan. No owner. No one can say what the spend should produce this quarter, or who answers for it. Name an accountable owner before adding budget or headcount.
Company B Growth from referrals looks fine, even good. No repeatable demand system behind the number. Lose three relationships and the pipeline goes with them. Build the system now, before a referral source dries up.
Company C Dashboards, monthly decks, a leader fluent in channels and campaigns. No line connecting any of it to revenue. No one can say which dollar produced which customer. Tie every report to a revenue outcome someone owns.
Three portfolio company panels evaluated against the same governance framework, each showing a different gap
Same diagnostic, three different findings.
Same visible symptom, three different fixes. Running the same three-lens diagnostic at each company is what keeps you from applying the wrong fix to the wrong one.

Portfolio Company Marketing Governance Checklist

Apply this at each portfolio company, on the same schedule, so the results are comparable across your holdings.
  • Who owns the growth number at the executive level, in writing, not by default?
  • What percentage of new revenue last quarter came from a channel this company can name and repeat, versus referral or luck?
  • Can the marketing leader answer budget, revenue responsibility, and measurement in under ten seconds?
  • Is there a written plan connecting current spend to a specific revenue target, or is spend justified by “what we’ve always done”?
  • Would this company’s growth survive a slow quarter of referrals, or is the business quietly dependent on luck?
  • Has marketing leadership turned over in the last eighteen months, and if so, did the system get rebuilt, or did the company just reset the clock?
Score each company against this list at acquisition, at the twelve-month checkpoint, and again ahead of exit. A company that fails three or more of these doesn’t have a marketing execution problem. It has a governance gap that belongs in your value creation plan, and it’s worth naming that way to the board rather than letting it hide inside a broader “marketing needs improvement” line item.

Get a clearer read before the next portfolio decision

A Strategic Growth Diagnostic shows whether the company has an ownership, system, or governance gap before more capital goes into execution. Schedule a Strategic Growth Diagnostic

What to Bring to the Investment Committee

When you take this to the board, the framing matters as much as the finding. Don’t present ungoverned marketing spend as a tactical fix. Present it as an unmanaged risk with a dollar figure attached, the same way you’d present customer concentration or a lapsed key contract. Here’s the structure that works: state which lens is failing (ownership, system, or governance), state the annual spend currently exposed to that gap, and state the timeline for closing it. That framing turns a marketing conversation into a capital allocation conversation, which is the conversation your investment committee is actually equipped to act on. Picture the difference in the room. “Marketing needs work at Company C” gets a nod and a follow-up meeting. “Company C is ungoverned, that’s roughly $400,000 a year with no owner of the outcome, and we close it in two quarters,” gets a decision. That’s the shift I’ve written about elsewhere: the real fix is leadership rather than tactics, not another campaign. Marketing leadership also carries one of the shortest average tenures in the C-suite, a pattern confirmed by Spencer Stuart’s own tenure research. That matters at the portfolio level because a leadership change at one company without a governance standard in place means starting the evaluation over again, on your clock, on the board’s dime. A governed standard survives the person. An ungoverned company does not. Where the read shows the gap is real, but a full-time executive isn’t justified at that company’s size, applying senior marketing leadership on a fractional basis gives you an accountable owner without a full salary on every cap table. The point isn’t to add headcount everywhere. It’s to match the level of ownership to what each company actually needs, then hold that owner to the numbers.

Building a Standard You Can Apply Across the Portfolio

The value of this approach isn’t that it fixes one company’s marketing. It’s that it gives you a single, repeatable standard you can apply the moment you inherit a new company, at the routine checkpoints in between, and again before an exit conversation. You stop re-deriving the answer from zero every time, and you start walking into board meetings with a comparable finding instead of a company-specific story. The first move at any portfolio company is not a hire, a termination, or a bigger budget. It is a Strategic Growth Diagnostic, a structured, executive-level read that shows where governance is actually missing at that company, before you commit more capital.

Stop evaluating every company from scratch

A Strategic Growth Diagnostic gives operating partners a repeatable read on whether marketing is owned, systemized, and tied to revenue before more spend gets approved. Schedule a Strategic Growth Diagnostic

Frequently Asked Questions

What is portfolio company marketing governance?It’s a repeatable standard for evaluating whether marketing at each portfolio company is owned, systemized, and tied to revenue, applied the same way at every company, instead of being reassessed from scratch each time.
How is this different from evaluating one company’s marketing?A single-company evaluation asks whether that company’s marketing is working. A portfolio standard asks whether you can compare Company A to Company B on the same terms, at the same checkpoints, so findings are board-ready rather than anecdotal.
How often should we run this diagnostic across the portfolio?Three points cover most of the risk: at acquisition or within the first 90 days, around the twelve-month mark, and again twelve to eighteen months ahead of a planned exit.
Do we need to hire a CMO at every portfolio company?Rarely, and almost never as a first move. Dropping a senior marketer into a company that has never defined who owns growth usually moves the confusion to a more expensive office. Diagnose the gap first, then match the level of leadership to what that specific company needs.
How does marketing governance affect exit value?A company whose growth depends on the operator staying involved reads as a risk in diligence and gets priced that way. Documented, owned, and governed growth reads as a durable asset. Closing the gap twelve to eighteen months before a sale is one of the cleaner ways to protect the multiple.
Portfolio marketing governance vs. a single-company marketing audit: What’s the difference?A single-company audit produces a list of things to improve at one business. A portfolio governance standard produces a comparable finding across every business you hold, applied the same way, so you can rank and prioritize across the portfolio rather than react company by company.
Is a Strategic Growth Diagnostic worth it if a portfolio company’s growth already looks fine?Referral-driven growth that looks fine is often the least diagnosed risk in a portfolio, because nothing is visibly broken. A diagnostic at a healthy-looking company is what catches a missing system before it shows up as a slow quarter.
Fractional CMO vs. hiring a full-time marketing director at each portfolio company, which is right?It depends on what the diagnostic finds, not on a default preference. Where the gap is real but doesn’t justify a full-time salary at that company’s size, fractional leadership closes it. Where the company has scale and complexity to match, a full-time hire may be the right call.
About the Author

By Mark Toney, CMO Strategy Pro

Mark Toney is the founder of CMO Strategy Pro, where he runs marketing evaluations and installs fractional marketing leadership at PE-backed portfolio companies. He has spent his career connecting marketing decisions to revenue and works directly with operating partners and portfolio company leadership through hold periods, from acquisition through exit.

Similar Posts